Rudy L. Juliano

Affiliations: 
University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Cell Biology, Biochemistry, Pharmacology
Google:
"Rudy Juliano"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Juliano RL. (2018) Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don't. Nucleic Acid Therapeutics. 28: 166-177
Yang B, Ming X, Abdelkafi H, et al. (2016) Retro-1 Analogues Differentially Affect Oligonucleotide Delivery and Toxin Trafficking. Chemmedchem
Yang B, Ming X, Cao C, et al. (2015) High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides. Nucleic Acids Research. 43: 1987-96
Carver K, Ming X, Juliano RL. (2014) Tumor cell-targeted delivery of nanoconjugated oligonucleotides in composite spheroids. Nucleic Acid Therapeutics. 24: 413-9
Juliano RL, Ming X, Carver K, et al. (2014) Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology. Nucleic Acid Therapeutics. 24: 101-13
Nakagawa O, Ming X, Carver K, et al. (2014) Conjugation with receptor-targeted histidine-rich peptides enhances the pharmacological effectiveness of antisense oligonucleotides. Bioconjugate Chemistry. 25: 165-70
Alam MR, Ming X, Nakagawa O, et al. (2013) Covalent conjugation of oligonucleotides with cell-targeting ligands. Bioorganic & Medicinal Chemistry. 21: 6217-23
Juliano RL, Carver K, Cao C, et al. (2012) Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides. Journal of Drug Targeting. 21: 27-43
Alam MR, Ming X, Fisher M, et al. (2011) Multivalent cyclic RGD conjugates for targeted delivery of small interfering RNA. Bioconjugate Chemistry. 22: 1673-81
Juliano RL, Ming X, Nakagawa O, et al. (2011) Integrin targeted delivery of gene therapeutics. Theranostics. 1: 211-9
See more...